Frontline Ltd. (0REH)
London Exchange · UK · prices in NOK · close of 15 Oct 2026
Key indicators
| Last close | NOK 518.90 |
|---|---|
| 52-week range | 207.76 – 544.80 |
| Return, 1 month / 3 months | +10.9% / +48.5% |
| Return, 1 year / 3 years | +159.4% / +206.0% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 42.3% |
| Worst drawdown (1 year) | -21.4% |
| Average daily value traded | 17.55M NOK |
| Dividend yield | 9.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Frontline Ltd. is a tanker company that transports crude oil by sea. It owns and operates a fleet of oil tankers, including very large crude carriers and Suezmax vessels, which it charters to oil companies and oil traders around the world. The company is incorporated in Bermuda, with its commercial and technical management handled from Norway. Its business depends on moving crude oil between producing regions and refineries, and it operates in the global shipping market for petroleum transport.
Frontline Ltd. trades under the code 0REH on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Frontline Ltd. (0REH) trades on the London Exchange in UK. It last closed at NOK 518.90 on 15 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 76 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 159.4% and over the last three months it rose 48.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 65.9% | ||
| From 52-week high | -4.8% | ||
| Momentum | 97 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 48.5% | ||
| 6-month return | 74.1% | ||
| 12-month return, skipping the last month | 134.0% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.4% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 17.55M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 9.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +10.9% |
| 3 months | +48.5% |
| 6 months | +74.1% |
| 1 year | +159.4% |
| 3 years | +206.0% |
| 5 years | +964.9% |
Signals
| 50-day / 200-day average | 397.54 / 312.78 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | NOK 24.5856 |
| 11 Jun 2026 | NOK 14.7722 |
| 11 Mar 2026 | NOK 9.9360 |
| 11 Dec 2025 | NOK 1.9146 |
| 11 Sep 2025 | NOK 3.5571 |
| 11 Jun 2025 | NOK 1.8139 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.